@article{article, title  = {{Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)—Trial in progress.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps582 }},

 year = {{2023}},

 month = {{2}},

 author = {{Kamat AM and Steinberg GD and Inman BA and Kates MR and Uchio EM and Porten SP and Roupret M and Redorta J and Catto JWF and Kulkarni GS and Powles T et al}},

 doi = {{10.1200/jco.2023.41.6_suppl.tps582}},

 volume = {{41}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{6_suppl}},

 pages = {{TPS582-TPS582}},

 note = {{Accessed on 2024/12/22}}}